Company / Capital Expenditures
MEDICINOVA INC Capital Expenditures History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.9K
FY2025
5-year range
$2.9K / $28.7K
FY2021-FY2025
Trend
-86.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $2,899 in FY2025 to $83,378 in FY2013.
Based on SEC 10-K filings.
$2,899 in FY2025 with a 3-year CAGR of -16.7%.
Declined from $5,010 to $2,899 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -16.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -16.7%, indicating a declining trend.
- In FY2025, capital expenditures decreased 86.4% year-over-year.
- Peak capital expenditures was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9K | -86.4% |
| FY2024 | $21.3K | +325.1% |
| FY2023 | $5.0K | +0.0% |
| FY2022 | $5.0K | -82.6% |
| FY2021 | $28.7K | +715.6% |
| FY2014 | $3.5K | -95.8% |
| FY2013 | $83.4K | +1270.2% |
| FY2012 | $6.1K | +0.0% |
| FY2011 | $6.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026